Cargando…
Brachydactyly Type A3 Is More Commonly Seen in Children With Short Stature But Does Not Affect Their Height Improvement by Growth Hormone Therapy
INTRODUCTION: To analyze the prevalence of brachydactyly type A3 (BDA3) in children with short stature and the effect on growth hormone (GH) therapy. METHODS: We analyzed the medical records of pediatric patients from July 2009 to July 2021. We included children with short stature defined as their h...
Autores principales: | Wu, Huahong, Li, Yang, Li, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851664/ https://www.ncbi.nlm.nih.gov/pubmed/35185800 http://dx.doi.org/10.3389/fendo.2022.824315 |
Ejemplares similares
-
Height outcomes in Korean children with idiopathic short stature receiving growth hormone treatment
por: Chae, Hyun Wook, et al.
Publicado: (2022) -
Association between uric acid and height during growth hormone therapy in children with idiopathic short stature
por: Yoon, Jong Seo, et al.
Publicado: (2022) -
Short stature related to Growth Hormone Insensitivity (GHI) in childhood
por: Mastromauro, Concetta, et al.
Publicado: (2023) -
Differences in Response to Recombinant Growth Hormone Therapy on Height Gain in Patients with Idiopathic Short Stature Vs. Patients with Growth Hormone Deficiency
por: Alzahrani, Ali K, et al.
Publicado: (2020) -
SUN-252 Comparison of Sitting Height/Height Ratio for Age in Children with Short Stature Caused by Defects in Growth Plate Genes
por: Vasques, Gabriela, et al.
Publicado: (2019)